Nicox SA (NICXF)
0.44
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nicox Total Liabilities (Quarterly): 34.89M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.89M |
| June 30, 2023 | 39.94M |
| June 30, 2023 | 39.94M |
| December 31, 2022 | 35.98M |
| June 30, 2022 | 40.26M |
| June 30, 2022 | 40.26M |
| December 31, 2021 | 44.22M |
| June 30, 2021 | 50.03M |
| June 30, 2021 | 50.03M |
| December 31, 2020 | 50.96M |
| June 30, 2020 | 60.21M |
| June 30, 2020 | 60.21M |
| December 31, 2019 | 37.54M |
| June 30, 2019 | 30.29M |
| June 30, 2019 | 30.29M |
| December 31, 2018 | 28.52M |
| June 30, 2018 | 28.63M |
| June 30, 2018 | 28.63M |
| December 31, 2017 | 28.84M |
| June 30, 2017 | 40.89M |
| June 30, 2017 | 40.89M |
| December 31, 2016 | 46.73M |
| June 30, 2016 | 68.01M |
| Date | Value |
|---|---|
| June 30, 2016 | 68.01M |
| December 31, 2015 | 67.80M |
| June 30, 2015 | 65.13M |
| June 30, 2015 | 65.13M |
| December 31, 2014 | 65.37M |
| June 30, 2014 | 10.71M |
| June 30, 2014 | 10.71M |
| December 31, 2013 | 14.91M |
| September 30, 2013 | 11.38M |
| June 30, 2013 | 11.19M |
| March 31, 2013 | 10.93M |
| December 31, 2012 | 12.69M |
| September 30, 2012 | 13.56M |
| June 30, 2012 | 12.37M |
| March 31, 2012 | 12.32M |
| December 31, 2011 | 14.90M |
| September 30, 2011 | 12.77M |
| June 30, 2011 | 13.39M |
| March 31, 2011 | 13.91M |
| December 31, 2010 | 16.55M |
| September 30, 2010 | 26.04M |
| June 30, 2010 | 25.85M |
| March 31, 2010 | 17.21M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.29M
Minimum
Jun 2019
60.21M
Maximum
Jun 2020
43.00M
Average
40.26M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 34.24M |
| Cellectis SA | 249.58M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 117.09M |
| Innate Pharma SA | 146.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.56M |
| Shareholders Equity (Quarterly) | 23.67M |
| Debt to Equity Ratio | 1.175 |
| Current Ratio | 8.967 |
| Net Debt Paydown Yield | -9.48% |